A collaborative effort between the Global Malaria Program of the World Health Organization (WHO) and the WorldWide Antimalarial Resistance Network (WWARN) has recently been launched.
Improved diagnosis and treatment of invasive bacterial disease are needed to reduce childhood mortality, in an area exposed to high transmission of malaria.
The increasing prevalence of multi-drug-resistant Plasmodium falciparum drives the ongoing need for the development of new antimalarial drugs.
While international funding to fight malaria has more than doubled in the past three years, producing positive results, much more money is needed, according to a new report from the World Health Organization (WHO).
Unfortunately malaria transmission in Africa is often assessed using routine administrative reports from local health units, which are plagued by sporadic reporting failures. It is unfortunate that WHO is also trying to plan and evaluate its malaria control efforts based on these same kinds of inadequate administrative reports.
Following the Bill and Melinda Gates declaration in 2007 that malaria eradication is their lifeterm goal, nearly every researcher and policy maker thinks this is feasible. The WHO has also made this a long term global target. I believe this agenda is too immature to be impemented in many malaria endemic countries, most of which are developing still. It will likely lead to imbalanced resource allocation for managing many other different diseases.